Creating an Obesity Treatment Plan in Primary Care

Eli Lilly Grant Funded Program

Obesity course description: In this 3 hour educational workshop, learners will be exposed to multiple aspects of diagnosing, treating, caring for, and preventing obesity among primary care patients. The workshop includes hands on activities, additional reading, and key practice tips such as identifying obesegenic medications and healthcare provider bias within the exam setting. The overall goal is to educate HCPs about the current issues related to obesity in order to promote advancement of care for patients nationwide.

Credits: 3.0 contact hours; 2.0 are Pharmacology

$30.00

Learning objectives

After taking part in this educational activity, participants should be better able to:

• Accurately screen and appropriately apply differential diagnosis for earlier diagnosis and timely intervention of obesity and comorbidities
• Effectively assess and manage obesity as a chronic, serious, and progressive disease warranting early intervention and long-term care to minimize related comorbidities, like diabetes and cardiovascular disease across diverse patient populations
• Comprehensively manage obesity with both behavior and lifestyle modifications as well as the inclusion of pharmacotherapy, highlighting the safety and efficacy of available marketplace treatment option
• Address disparity gaps within practice while effectively integrating more cultural sensitivity to all patient visits

CE INFORMATION

Obtain Your Credits

To earn credits for this activity, navigate to the Content(s) tab and complete all course components in the following order: 

1) Complete the Pre-test

2) Watch the course presentation video 

2) Complete the course evaluation

3) Pass the post-test with a score of 2/3 (66.7%) or higher. You may retake the post-test until a passing score is achieved, at which point you will be able to view/print a copy of your certificate of completion. 

This online certificate will also be saved within your profile 'My Dashboard' -> 'Transcript/Certificates Earned'  for future access.

Designation Statement

NPACE designates this educational activity for a maximum of 3.00 contact hours, of which 2.0 is pharmacology credit. Participants should claim only credit commensurate with the extent of their participation in the activity.

Accreditation Statement

Nurse Practitioners Associates for Continuing Education (NPACE) is accredited as a provider of nursing continuing professional development by the American Nurse Credentialing Center's Commission on Accreditation (ANCC)

In addition to ANCC, NPACE is approved as a provider of continuing education in nursing by: the California Board of Registered Nursing, Provider Number CEP8720 and Florida CE Broker #50-1476.

DISCLOSURES

Faculty

Contributing faculty, Christine Kessler, MN, ACCNS, ANP-BC BC-ADM, FAANP has disclosed have disclosed: 

Novo Nordisk; Obesity & T2DM - Promotional speaker & Advisory board
Acella: Thyroid - Advisory board & Promotional speaker

Contributing faculty, Angela Golden, DNP, FNP-C, FAANP, FOMA has disclosed have disclosed: 

Novo Nordisk: Obesity - Promotional speaker & Advisory board

Acella: Thyroid - Advisory board & Promotional speaker
Gelesis: Obesity - Advisory board
Currax: Obesity - Advisory board & Promotional speaker
Lilly: Obesity and Sleep apnea - Advisory Board
WW: Obesity - Advisory board
SetPoint: Obesity - Advisor
Springer: Obesity - Author

Planners

All planners and contributors involved in this educational activity have disclosed no relevant financial relationships. 

Disclaimer

The material presented in this continuing education program is being made available for educational purposes only and is not intended to represent the best or only methods, medications and/or guidelines appropriate for the medical situation discussed. Rather the material is intended to present an approach, view, statement, or opinion of the presenter(s), which may be helpful, or of interest to other practitioners and should not be used by clinicians without the evaluation of their patient’s conditions and possible contraindications on dangers in use, review of any applicable manufacturer’s product information, and comparison with recommendations of other authorities. NPACE disclaims any liability, loss, injury, or damage incurred as a consequence, directly or indirectly, of the use and application of any information given in a presentation.

Disclosure of Unlabeled Use

This educational activity may mention the uses of products that are not approved by the FDA for the indication(s) being discussed. The presenter(s) are instructed to notify participants when they are discussing unapproved uses or investigational agents. The opinions related to unapproved uses of products are solely those of the presenter(s) and are not endorsed or recommended by NPACE. Please refer to the official prescribing information for each product for discussion of approved indications, contraindications, and warnings.

Commercial Support

This education is funded through a generous educational grant from Lilly.